[1] Sorensen JB, Hansen HH, Hansen M, et al. Brain metastases in adenocarcinoma of the lung: frequency, risk groups and prognosis[J]. J Clin Oncol, 1988, 6(9): 1474-80. [2] Boyd TS, Mehta MP. Stereotactic radiosurgery for brain metastases (Review)[J].Oncology, 1999, 13: 1397-409. [3] Mehta MP, Shapiro WR, Glantz MJ, et al. Lead-in phase to randomized trial ofmotexafin gadolinium and whole-brain radiation for patients with brain metastases: Centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic end points[J]. J Clin Oncol, 2002, 20: 3445-53. [4] Westphal M, Heese O. Intracranial metastases: therapeutic options[J]. Ann Onc, 2003, 14(3): iii4-10. [5] Kondziolka D, Patel A, Lunsford LD, et al. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases[J].Int J Radiat Oncol Biol Phys,1999, 45(2): 427-34. [6] 漆松涛,刘承勇.脑转移瘤的X刀治疗与常规手术疗效比较[J].第一军医大学学报(J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao),2000,20(2):150-1. [7] Aoyama H, Shirato H, Onimaru R, et al. Hypofractionated stereotactic radiotherapy alone without whole-brain irradiation for patients with solitary and oligo brain metastasis using noninvasive fixation of the skull[J]. Int J Radiat Oncol Biol Phys, 2003, 56(3): 793-800. [8] DeAngelis L, Delattre J, Posner J. Radiation induced dementia in patients cured of brain metastases[J]. Neurology, 1989, 39(6): 789-96. [9] Sneed PK, Suh JH, Goetsch SJ, et al. A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases[J]. Int J Radiat Oncol Biol Phys, 2002, 53(3): 519-26. [10] Sneed PK, Lamborn KR, Forstner JM, et al. Radiosurgery for brain metastases: Is whole brain radiotherapy necessary[J]. Int J Radiat Oncol Biol Phys, 1999, 43(3): 549-58. [11] Pirzkall A, Debus J, Lohr F, et al. Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases[J]. J Clin Oncol, 1998, 16(11): 3563-9. [12] Regine WF, Huhn JL, Patchell RA, et al. Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagnosed brain metastases: results and implications[J]. Int J Radiat Oncol Biol Phys, 2002, 52(2): 333-8. [13] Christina A, Meyers D, Jennifer A, et al. Neurocognitive function and progression in patients with brain met-astases treated with whole-brain radiation and motexafin gadolinium: Results of a randomized phase Ⅲ trial[J]. J Clin Oncol, 2004, 22(1): 157-65. [14] Zabel A, Debus J. Treatment of brain metastases from non-small-cell lung cancer (NSCLC): radiotherapy[J]. Lung Cancer, 2004, 45(Suppl 2): 247-52. [15] Stuschke M, Eberhardt W, Pottgen C, et al. Prophylactic cranial Irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: Long-term follow-up and investigations of late neuropsychologic effects[J]. J Clin Oncol, 1999, 17(9):2700-9. [16] Gerosa M, Nicolato A, Foroni R. Analysis of long-term outcomes and prognostic factors in patients with non-small cell lung cancer brain metastases treated by gamma knife radiosurgery[J]. J Neurosurg, 2005, 102 (Suppl):75-80. |